Recombinant Interferon Beta Gel as an Adjuvant in the Treatment of Recurrent Genital Warts: Results of a Placebo-Controlled Double-Blind Study in 120 Patients

199829 citationsJournal Article

Authors

Gerd Gross · Universität Hamburg

T. Rogozinski

Helmut Schöfer

S. Jabłońska

A. Roussaki

C. Wöhr · Rentschler Biopharma (Germany)

Josef Brzoska · Rentschler Biopharma (Germany)

Abstract

Topical application of gel containing 0.15 x 10(6) IU/g recombinant IFN-beta is safe and appears to reduce the recurrence of CA after surgical treatment.

Topics & Keywords

Cervical Cancer and HPV Research Nail Diseases and Treatments Infectious Diseases and Mycology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Dermatology

Volume 196, Issue 3, pp. 330-334

DOI: 10.1159/000017906

Field-Weighted Citation Impact: 2.38